New schizophrenia drug shows promise in reducing symptoms
Symptom relief
Completed
This study tested a new medication, HS-10380, in 363 Chinese adults hospitalized with acute schizophrenia. The goal was to see if the drug reduces symptoms like hallucinations and delusions better than a placebo or an existing treatment over 6 weeks. The main measure was change i…
Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC